Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

What Is the Cost of Disease Progression Among Patients with Indolent or Aggressive Non-Hodgkin Lymphoma (NHL)?

Nicole Engel-Nitz, PhD, Stacey Dacosta Byfield, PhD MPH, Timothy Bancroft, PhD, Anderson J. Amy, M.S., Carolina Reyes, PhD, May Chen, MD, Matthew J. Matasar, MD MS

Blood (2016) 128 (22): 5957.

https://doi.org/10.1182/blood.V128.22.5957.5957

Published: 2016

Journal Articles

Real-World Health Care Utilization and Costs Among Patients Newly Initiating Systemic Therapy for Chronic Lymphocytic Leukemia (CLL) in the United States

Matthew J. Matasar, MD MS, Stacey Dacosta Byfield, PhD MPH, Cori Blauer-Peterson, MPH, Melissa Montez, PharmD, Carolina Reyes, PhD, Anthony Masaquel, PhD MPH

Blood (2016) 128 (22): 5928.

https://doi.org/10.1182/blood.V128.22.5928.5928

Published: 2016

Journal Articles

What Do Patients Prioritize in Selecting Chronic Lymphocytic Leukemia (CLL) Treatments?

Carol Mansfield, PhD, Anthony Masaquel, MPH, PhD, Jessie Sutphin, Elisa S Weiss, PhD, Meghan E. Gutierrez, Jennifer Wilson, Jia Li, PhD, Carolina Reyes, PhD

Blood (2016) 128 (22): 1239.

https://doi.org/10.1182/blood.V128.22.1239.1239

Published: 2016

Journal Articles

What Is the Cost-Effectiveness of Obinutuzumab Plus Bendamustine Followed By Obinutuzumab Monotherapy for the Treatment of Follicular Lymphoma Patients Who Relapse after or Are Refractory to a Rituximab-Containing Regimen in the US?

Gregory F. Guzauskas, MSPH, PhD, Anthony Masaquel, MPH, PhD, Carolina Reyes, PhD, Kenneth Wilhelm, MD, Tania Krivasi, MSc, David L. Veenstra, PharmD, PhD

Blood (2016) 128 (22): 3605.

https://doi.org/10.1182/blood.V128.22.3605.3605

Published: 2016

Journal Articles

Differences in Patients with Progressive Versus Non-Progressive AML, CLL, or NHL: Implications for Proposed Bundled Payment Strategies

Stacey Dacosta Byfield, PhD MPH, Nicole Engel-Nitz, PhD, Timothy Bancroft, PhD, Amy J Anderson, MS, Carolina Reyes, PhD, Arliene Ravelo, MPH, Sarika Ogale, PhD, May Chen, MD, Matthew J. Matasar, MD MS

Blood (2015) 126 (23): 4528.

https://doi.org/10.1182/blood.V126.23.4528.4528

Published: 2015

Journal Articles

Real-World Outcomes Among Elderly Acute Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Bruno C Medeiros, MD, Sacha Satram-Hoang, PhD, Khang Q. Hoang, DO, Faiyaz Momin, MS, Deborah Hurst, MD, Carolina Reyes, PhD

Blood (2014) 124 (21): 2271.

https://doi.org/10.1182/blood.V124.21.2271.2271

Published: 2014

Journal Articles

Comparative Effectiveness of Chemotherapy in an Elderly Acute Myeloid Leukemia Population in the United States

Bruno C Medeiros, MD, Sacha Satram-Hoang, PhD, Khang Q. Hoang, DO, Faiyaz Momin, MS, Deborah Hurst, MD, Carolina Reyes, PhD

Blood (2014) 124 (21): 2272.

https://doi.org/10.1182/blood.V124.21.2272.2272

Published: 2014

Journal Articles

Cost-Effectiveness Analysis of Obinutuzumab Versus Ofatumumab for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

Carolina Reyes, PhD, Gregory Gazauskas, PhD, Ursula Becker, MSc, Santiago Moreno, David L. Veenstra, PharmD, PhD

Blood (2014) 124 (21): 1324.

https://doi.org/10.1182/blood.V124.21.1324.1324

Published: 2014

Journal Articles

Big Data Analysis of Treatment Patterns and Outcomes Among Elderly Medicare Acute Myeloid Leukemia Patients

Sacha Satram-Hoang, PhD, Carolina Reyes, PhD, Khang Q. Hoang, DO, Faiyaz Momin, MS, Deborah Hurst, MD, Bruno C Medeiros, MD

Blood (2014) 124 (21): 3698.

https://doi.org/10.1182/blood.V124.21.3698.3698

Published: 2014

Journal Articles

Differences In Treatment Patterns and Costs Among Diffuse Large B-Cell Lymphoma Patients Treated In The Clinic Vs. The Hospital Outpatient Setting

Carolina Reyes, PhD, Stacey Dacosta Byfield, Laura K. Becker, MS, Art Small, MD

Blood (2013) 122 (21): 1751.

https://doi.org/10.1182/blood.V122.21.1751.1751

Published: 2013

Journal Articles

How Many Life Years Have Been Saved In The United States From Using Rituximab Plus Chemotherapy Compared To Chemotherapy Alone From 1998-2013

Mark Danese, PhD, Michelle Gleeson, PhD, Marc Halperin, Sandra Skettino, M.D., Carolina Reyes, PhD

Blood (2013) 122 (21): 2937.

https://doi.org/10.1182/blood.V122.21.2937.2937

Published: 2013

Journal Articles

The Under-Treatment of Elderly Medicare Diffuse Large B-Cell Lymphoma Patients

Sacha Satram-Hoang, Ph.D., Sandra Skettino, M.D., Khang Hoang, D.O., Sridhar R Guduru, M.S., Ashok Gunuganti, M.S., Carolina Reyes, Ph.D.

Blood (2012) 120 (21): 237.

https://doi.org/10.1182/blood.V120.21.237.237

Published: 2012

Journal Articles

Does Faster Rituximab Infusion for Patients with NHL Lower Cancer Care Costs?

John Hornberger, MD, MS, Minghan Dai, MPH, Hans-Peter Goertz, MPH, Keith L Dawson, MS, RN, Carolina Reyes, Ph.D.

Blood (2012) 120 (21): 2063.

https://doi.org/10.1182/blood.V120.21.2063.2063

Published: 2012

Journal Articles

Which Patient Characteristics Impact Treatment Choice in Elderly Patients with Chronic Lymphocytic Leukemia?

Sacha Satram-Hoang, Ph.D., Carolina Reyes, Ph.D., Khang Hoang, D.O., Faiyaz Momin, M.S., Sridhar R Guduru, M.S., Sandra Skettino, M.D.

Blood (2012) 120 (21): 967.

https://doi.org/10.1182/blood.V120.21.967.967

Published: 2012

Journal Articles

Are There Differences in Patient Characteristics, Treatment Patterns and Costs by Treatment Setting?

Stacey Dacosta Byfield, Carolina Reyes, Ph.D., Laura K Becker, MS, Art Small, MD

Blood (2012) 120 (21): 4259.

https://doi.org/10.1182/blood.V120.21.4259.4259

Published: 2012

Journal Articles

What Is the Impact of Comorbidity Burden On Treatment Patterns and Outcomes in Elderly Chronic Lymphocytic Leukemia Patients?

Carolina Reyes, Ph.D., Sacha Satram-Hoang, Ph.D., Khang Hoang, D.O., Faiyaz Momin, M.S., Sridhar R Guduru, M.S., Sandra Skettino, M.D.

Blood (2012) 120 (21): 758.

https://doi.org/10.1182/blood.V120.21.758.758

Published: 2012

Journal Articles

Symptoms and Toxicity of Rituximab Maintenance (R-M) Versus Observation (OBS) Following Rituximab Plus Chemotherapy in Patients with Follicular Lymphoma,

Xiaolei Zhou, Jianmin Wang, Jessica Zhang, Catherine Copley-Merriman, Yasuhiro Torigoe, Carolina Reyes, PhD, John F. Seymour, MD, PhD, Armando Lopez-Guillermo, MD, Fritz C. Offner, MD, PhD, Marek Trneny, Gilles Andre Salles

Blood (2011) 118 (21): 3661.

https://doi.org/10.1182/blood.V118.21.3661.3661

Published: 2011

Journal Articles

Is There a Difference in Treatment Patterns Among Follicular Lymphoma Patients Receiving Care in the Outpatient Hospital Versus the Community Clinic Setting?

Sacha Satram-Hoang, Ph.D., Carolina Reyes, PhD

Blood (2011) 118 (21): 3134.

https://doi.org/10.1182/blood.V118.21.3134.3134

Published: 2011

Journal Articles

An observational study of outcomes after initial infused therapy in Medicare patients diagnosed with chronic lymphocytic leukemia

Mark D. Danese, Robert I. Griffiths, Michelle Gleeson, Sacha Satram-Hoang, Kevin Knopf, Joseph Mikhael, Carolina Reyes

Blood (2011) 117 (13): 3505–3513.

https://doi.org/10.1182/blood-2010-08-301929

Published: 2011

Includes: Supplemental data

Journal Articles

Economic Impact of Disease Progression In Follicular Non-Hodgkin's Lymphoma.

Sacha-Satram Hoang, PhD, Stephen Gruschkus, PhD, Joseph Darragh, MS, Michael Forsyth, RPh, MBA, Roy Beveridge, MD, Carolina Reyes, PhD

Blood (2010) 116 (21): 1522.

https://doi.org/10.1182/blood.V116.21.1522.1522

Published: 2010

NARROW

What Is the Cost of Disease Progression Among Patients with Indolent or Aggressive Non-Hodgkin Lymphoma (NHL)?

Real-World Health Care Utilization and Costs Among Patients Newly Initiating Systemic Therapy for Chronic Lymphocytic Leukemia (CLL) in the United States

What Do Patients Prioritize in Selecting Chronic Lymphocytic Leukemia (CLL) Treatments?

What Is the Cost-Effectiveness of Obinutuzumab Plus Bendamustine Followed By Obinutuzumab Monotherapy for the Treatment of Follicular Lymphoma Patients Who Relapse after or Are Refractory to a Rituximab-Containing Regimen in the US?

Differences in Patients with Progressive Versus Non-Progressive AML, CLL, or NHL: Implications for Proposed Bundled Payment Strategies

Real-World Outcomes Among Elderly Acute Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Comparative Effectiveness of Chemotherapy in an Elderly Acute Myeloid Leukemia Population in the United States

Cost-Effectiveness Analysis of Obinutuzumab Versus Ofatumumab for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

Big Data Analysis of Treatment Patterns and Outcomes Among Elderly Medicare Acute Myeloid Leukemia Patients

Differences In Treatment Patterns and Costs Among Diffuse Large B-Cell Lymphoma Patients Treated In The Clinic Vs. The Hospital Outpatient Setting

How Many Life Years Have Been Saved In The United States From Using Rituximab Plus Chemotherapy Compared To Chemotherapy Alone From 1998-2013

The Under-Treatment of Elderly Medicare Diffuse Large B-Cell Lymphoma Patients

Does Faster Rituximab Infusion for Patients with NHL Lower Cancer Care Costs?

Which Patient Characteristics Impact Treatment Choice in Elderly Patients with Chronic Lymphocytic Leukemia?

Are There Differences in Patient Characteristics, Treatment Patterns and Costs by Treatment Setting?

What Is the Impact of Comorbidity Burden On Treatment Patterns and Outcomes in Elderly Chronic Lymphocytic Leukemia Patients?

Symptoms and Toxicity of Rituximab Maintenance (R-M) Versus Observation (OBS) Following Rituximab Plus Chemotherapy in Patients with Follicular Lymphoma,

Is There a Difference in Treatment Patterns Among Follicular Lymphoma Patients Receiving Care in the Outpatient Hospital Versus the Community Clinic Setting?

An observational study of outcomes after initial infused therapy in Medicare patients diagnosed with chronic lymphocytic leukemia

Economic Impact of Disease Progression In Follicular Non-Hodgkin's Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only